NIMBLE, NCT05070858 / 2020-003272-41: A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis |
|
|
| Recruiting | 3 | 235 | Europe, Canada, Japan, US, RoW | Pozelimab + Cemdisiran, Cemdisiran, ALN-CC5, Placebo, Pozelimab, REGN3918 | Regeneron Pharmaceuticals | Generalized Myasthenia Gravis | 05/25 | 03/28 | | |
NCT06116045: Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder |
|
|
| Recruiting | 2 | 30 | RoW | BZ371A 7.5 mg (1.5 ml), BZ371A, BZ371A 5.0 mg (1.0 ml), BZ371A 2.5 mg (0.5 ml), Placebo (1.5 ml), Placebo, Placebo (1.0 ml), Placebo (0.5 ml) | Biozeus Biopharmaceutical S.A. | Female Sexual Arousal Disorder, Female Sexual Dysfunction | 02/25 | 03/25 | | |
